Clinical Trials Logo

Chronic Obstructive Pulmonary Disease clinical trials

View clinical trials related to Chronic Obstructive Pulmonary Disease.

Filter by:

NCT ID: NCT00777595 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers

CT14
Start date: October 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of single doses of therapeutic and supratherapeutic doses of inhaled CHF 4226 pMDI on ventricular repolarization in healthy subjects compared with placebo.

NCT ID: NCT00774761 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.

NCT ID: NCT00774176 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations

PA-SCOPE
Start date: June 2004
Phase: N/A
Study type: Observational

The overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for chronic obstructive pulmonary disease (COPD)— and then to show that repeat acute exacerbations in high-risk patients can be reduced with one simple intervention. We believe that 1) COPD patients who are black or who live in rural areas of Pennsylvania are at higher risk of acute exacerbations requiring hospitalization and 2) this elevated risk can be reduced with one simple intervention: access to a 1-800 Temple Call Center where patients can get immediate customized advice on managing COPD exacerbations in their early stages. We will test these beliefs in PA-SCOPE. The collaborators with Temple University Hospital on the PA-SCOPE project are Lancaster General Hospital, Western Pennsylvania Hospital, and the Philadelphia College of Osteopathic Medicine.

NCT ID: NCT00773786 Completed - COPD Clinical Trials

Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

Start date: October 2008
Phase: Phase 4
Study type: Interventional

This will be a double-blind crossover trial in 20 patient with stable COPD. Data from this study will provide proof-of-concept information on whether the (anticipated) additional bronchodilator effect of Brovana added to tiotropium will lead to a meaningful improvement in the patient-centered outcome, exercise capacity. This study will only evaluate the effects of short-term (1-week) administration of Brovana. If results are positive, it would provide preliminary data for further, multicenter investigations.

NCT ID: NCT00772733 Completed - COPD Clinical Trials

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

KOSMOS
Start date: October 2008
Phase: N/A
Study type: Observational

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

NCT ID: NCT00766415 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

14729-D9831C00002- 1 Month Biopsy Study

Biopsy
Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to study histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

NCT ID: NCT00764556 Completed - COPD Clinical Trials

Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards

IPS2008
Start date: May 2008
Phase: Phase 2
Study type: Interventional

Patients with chronic obstructive pulmonary disease (COPD) are commonly admitted to hospital with exacerbations of their lung disease. A combination of the acute illness and treatment with oral steroids causes a rise in blood sugar. Patients with high blood sugar do worse than those with normal blood sugar. The aim of this study is to develop a safe and effective protocol for tight control of blood glucose with insulin on acute medical wards outside the intensive care environment. This will allow us to perform a formal trial to determine whether blood glucose control with insulin reduces death and complications from COPD exacerbations.

NCT ID: NCT00758706 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients

BICO
Start date: September 2008
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to investigate the effects of AZD1236 compared with placebo ("inactive substance") in COPD patients by analysing biomarkers for inflammation and tissue degradation in blood, urine and sputum.

NCT ID: NCT00758459 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients

CERA
Start date: September 2008
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to investigate the tolerability and safety of AZD 1236 compared with placebo ("inactive substance") in COPD patients by assessment of Adverse Events, vital signs and laboratory safety assessments.

NCT ID: NCT00754546 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD

ARFEET
Start date: August 2008
Phase: Phase 4
Study type: Interventional

Previous studies suggest that treadmill exercise may be a more relevant exercise stimulus than the cycle ergometer to demonstrate benefits with bronchodilator therapy in patients with COPD. The hypothesis of the study is that patients with COPD will exhibit greater improvements in exercise endurance and breathlessness with arformoterol compared with normal saline during treadmill walking than with cycle exercise.